|The Nordic Group is a privately owned, pan-European pharmaceutical company, with a strong focus on the development and commercialization of niche hospital and orphan products. Nordic Group has a presence in 17 European countries, operating under the name of Nordic Pharma and Nordic Drugs. Nordic (which was already marketing an aprotinin product in UK) acquired rights to TRASYLOL® from Bayer in July 2012, worldwide excluding the United States. Additional information can be obtained at http://www.nordicpharmagroup.com/|
|We are Abbott Point of Care a part of Abbott Laboratories Limited, a global, diversified health care innovator with a legacy of pioneering work in medical Diagnostics.
Our i-STAT® System is an advanced, portable diagnostic testing system that provides real-time results within minutes to accelerate the patient care decision-making process.